Real-world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy.
Sejin LeeAntonia V BennettXi ZhouAllison Betof WarnerJustin G TrogdonErin E KentJennifer L LundPublished in: Pharmacoepidemiology and drug safety (2023)
Our findings inform understanding of treatment patterns of currently used immunotherapies and targeted therapies in older adults with advanced melanoma. Immunotherapy use has increased steadily with PD-1 inhibitors becoming a dominant treatment option since 2015.